$EXEL Cabometyx recommended for EU approval in 2L liver cancer http://ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2368377 … US PDUFA date is 14 Jan 2019
More From BioPortfolio on "$EXEL Cabometyx recommended for EU approval in 2L liver cancer http://ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2368377 … US PDUFA date is 14 Jan 2019"